会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Glass antenna system for an automobile
    • 汽车玻璃天线系统
    • US4439771A
    • 1984-03-27
    • US378329
    • 1982-05-14
    • Masaharu KumeKenichi IshiiTakayasu Hokusho
    • Masaharu KumeKenichi IshiiTakayasu Hokusho
    • H01Q1/32B60J1/00H01Q1/12H01Q1/02
    • H01Q1/1278
    • A glass antenna system for an automobile comprises a main antenna disposed at an upper part of a glass plate for a rear window of the automobile and a defogging electric heating element disposed below and separate from the main antenna and comprising a plurality of heating strips and a pair of bus bars for supplying electricity to the heating strips. The glass antenna system is characterized in that a lead wire is connected to a predetermined portion of the lower most heating strip among said heating strips and a feeding point for connection to an antenna feeder line is provided on the lead wire, whereby the defogging electric heating element constitutes a subsidiary antenna having a directivity different from the directivity of the main antenna.
    • 一种用于汽车的玻璃天线系统包括设置在汽车后窗玻璃板的上部的主天线和设置在主天线下方并与主天线分离的除雾电加热元件,并且包括多个加热带和 一对用于向加热带供电的母线。 玻璃天线系统的特征在于,引线与所述加热带中的最下部加热条的预定部分连接,并且在引线上设置用于连接到天线馈线的馈电点,由此除雾电加热 元件构成具有与主天线的方向性不同的方向性的辅助天线。
    • 4. 发明授权
    • Quinazoline derivatives having tyrosine kinase inhibitory activity
    • 具有酪氨酸激酶抑制活性的喹唑啉衍生物
    • US08202879B2
    • 2012-06-19
    • US11884819
    • 2006-02-22
    • Masaharu KumeKenji MatsuoNaoki OmoriMasami Takayama
    • Masaharu KumeKenji MatsuoNaoki OmoriMasami Takayama
    • A01N43/54A61K31/517C07D239/72
    • C07D239/94C07D401/12C07D401/14C07D405/06C07D405/12C07D407/12C07D417/12
    • A compound which inhibits both of EGF receptor tyrosine kinase and HER2 tyrosine kinase is provided.A compound represented by the general formula (I): wherein RX is a group represented by the formula: wherein R1 is a hydrogen atom, optionally substituted alkyl, etc.; Z is —O—, —N(R10)—, etc.; R10 is a hydrogen atom, alkyl, etc.; R2 is a hydrogen atom, optionally substituted alkyl, etc.; R18 is a hydrogen atom, optionally substituted alkyl, etc.; R19 is optionally substituted alkyl, etc.; W1 is an optionally substituted non-aromatic nitrogen-containing group; R17 is a hydrogen atom, optionally substituted alkyl, etc.; R3 and R4 are independently a hydrogen atom, optionally substituted alkyl, etc.; X is —O—, —S—, or —N(R12)—, etc.; R12 is a hydrogen atom, alkyl, etc.; and A is phenyl optionally having a substituent, etc., its pharmaceutically acceptable salt, or a solvate thereof.
    • 提供抑制EGF受体酪氨酸激酶和HER2酪氨酸激酶两者的化合物。 由通式(I)表示的化合物:其中RX是由下式表示的基团:其中R1是氢原子,任选取代的烷基等; Z是-O - , - N(R 10) - 等; R10是氢原子,烷基等; R2是氢原子,任选取代的烷基等; R18是氢原子,任意取代的烷基等; R19是任选取代的烷基等; W1是任选取代的非芳族含氮基团; R 17是氢原子,任选取代的烷基等; R3和R4独立地是氢原子,任选取代的烷基等; X是-O-,-S-或-N(R 12) - 等; R12是氢原子,烷基等; 和A是任选具有取代基的苯基等,其药学上可接受的盐或其溶剂合物。
    • 9. 发明申请
    • Quinazoline Derivatives Having Tyrosine Kinase Inhibitory Activity
    • 具有酪氨酸激酶抑制活性的喹唑啉衍生物
    • US20090143414A1
    • 2009-06-04
    • US11884819
    • 2006-02-22
    • Masaharu Kume
    • Masaharu Kume
    • A61K31/517C07D413/02C07D403/02C07D239/72
    • C07D239/94C07D401/12C07D401/14C07D405/06C07D405/12C07D407/12C07D417/12
    • A compound which inhibits both of EGF receptor tyrosine kinase and HER2 tyrosine kinase is provided.A compound represented by the general formula (I): wherein RX is a group represented by the formula: wherein R1 is a hydrogen atom, optionally substituted alkyl, etc.; Z is —O—, —N(R10)—, etc.; R10 is a hydrogen atom, alkyl, etc.; R2 is a hydrogen atom, optionally substituted alkyl, etc.; R18 is a hydrogen atom, optionally substituted alkyl, etc.; R19 is optionally substituted alkyl, etc.; W1 is an optionally substituted non-aromatic nitrogen-containing group; R17 is a hydrogen atom, optionally substituted alkyl, etc.; R3 and R4 are independently a hydrogen atom, optionally substituted alkyl, etc.; X is —O—, —S—, or —N(R12)—, etc.; R12 is a hydrogen atom, alkyl, etc.; and A is phenyl optionally having a substituent, etc., its pharmaceutically acceptable salt, or a solvate thereof.
    • 提供抑制EGF受体酪氨酸激酶和HER2酪氨酸激酶两者的化合物。 由通式(I)表示的化合物:其中RX是由下式表示的基团:其中R1是氢原子,任选取代的烷基等; Z是-O - , - N(R 10) - 等; R10是氢原子,烷基等; R2是氢原子,任选取代的烷基等; R18是氢原子,任意取代的烷基等; R19是任选取代的烷基等; W1是任选取代的非芳族含氮基团; R 17是氢原子,任选取代的烷基等; R3和R4独立地是氢原子,任选取代的烷基等; X是-O-,-S-或-N(R 12) - 等; R12是氢原子,烷基等; 和A是任选具有取代基的苯基等,其药学上可接受的盐或其溶剂合物。